In particular, several research groups showed that VE-cadherin in liver sinusoid endothelial cells was activated in patients with NAFLD (Kan et al., 2016), and steatotic hepatocytes suppress E-cadherin compared to normal hepatocytes (Pan et al., 2015). Here, CDH5 is linked to metabolic dysfunction-associated steatotic liver disease.